Flow Cytometric Determination of Lactic Acid Bacteria Viability: Principles, Methods, and Applicatio

Flow cytometric determination of lactic acid bacteria viability is a rapid, single-cell analytical technique that quantifies live, dead, and injured cells in probiotic products and fermented foods within minutes. Based on fluorescent viability staining and internationally recognized methodologies such as ISO 19344 / IDF 232, this approach delivers objective survival-rate data that complements traditional plate counting. This article explains the technical principle, sample types, testing workflow, quality controls, and practical applications of flow cytometry-based lactic acid bacteria viability testing in accredited third-party laboratories.

Technical Overview

Flow cytometry is a high-throughput, single-cell analysis platform widely used to determine the viability and survival rate of lactic acid bacteria (LAB) such as Lactobacillus, Lactococcus, Streptococcus thermophilus, Pediococcus, Leuconostoc, and Bifidobacterium species. In a flow cytometer, suspended bacterial cells are hydrodynamically focused into a single-cell stream and interrogated one by one by one or more laser beams. Each cell generates forward scatter (FSC), side scatter (SSC), and fluorescence signals that are captured by photomultiplier detectors and converted into digital event data.

Viability assessment is achieved through fluorescent probes that report on distinct physiological markers. Esterase-activity substrates such as carboxyfluorescein diacetate (CFDA) or CFDA-AM diffuse into metabolically active cells and are enzymatically cleaved to fluorescent carboxyfluorescein, which is retained by cells with intact membranes. Membrane-integrity dyes such as propidium iodide (PI) or ethidium homodimer enter only cells with compromised membranes and fluoresce upon binding nucleic acids. Dual-staining strategies allow every event to be classified as active (viable), dead, or injured (doubly stained or intermediate) cells, yielding both the total cell concentration and the viability percentage in a single run.

The internationally recognized methodological framework for this analysis is provided by ISO 19344 / IDF 232 (Milk and milk products — Enumeration of lactic acid bacteria — Flow cytometry principle), which defines staining, acquisition, and calculation procedures for determining active fluorescent units (AFU) and total fluorescent units. Flow cytometric results are typically reported alongside or correlated with classical culture-based enumeration methods such as ISO 7889 / IDF 94, ISO 20128, and ISO 29981 during method validation.

• Rapid turnaround: results are generated in under one hour, compared with 48–72 hours for plate counts.
• Single-cell resolution: provides quantitative distribution data rather than a colony-forming aggregate.
• Detection of viable-but-non-culturable (VBNC) cells that plate methods underestimate.
• Multiparametric output: simultaneous quantification of total counts, active counts, and dead-cell fractions.
• Excellent precision and wide linear dynamic range, typically 10⁴ to 10⁹ cells per gram after dilution.

Testing Samples

Probiotic Finished Products

Freeze-dried probiotic powders, encapsulated powders, hard capsules, compressed tablets, sachets, stick packs, gummies, and oral suspensions containing single or multi-strain lactic acid bacteria formulations. These samples are the most common submission type for label-claim verification and batch release testing.

Fermented Dairy and Plant-Based Products

Yogurt, drinking yogurt, fermented milks, kefir, cultured cream, cheese, and plant-based fermented alternatives. Dairy matrices typically require trisodium citrate or other dispersing agents to dissolve protein micelles and release entrapped bacterial cells before staining.

Starter Cultures and Biomass Concentrates

Direct vat set (DVS) and direct vat inoculation (DVI) frozen or freeze-dried starter culture concentrates, deep-frozen pellets, and fermentation broth samples collected upstream of drying or packaging operations.

Animal Feed and Agricultural Products

Silage inoculants, probiotic feed additives, fermented liquid feeds, and pet supplements containing lactic acid bacteria, where viability directly determines product efficacy.

Process and Stability Study Samples

In-process intermediates from fermentation, centrifugation, spray-drying, freeze-drying, and encapsulation steps, as well as samples from accelerated and real-time stability programs and stress-challenge studies.

Testing Items

• Total bacterial cell concentration (total fluorescent units per gram or per milliliter).
• Active viable cell concentration (active fluorescent units, AFU/g or AFU/mL).
• Dead cell concentration and percentage of membrane-compromised cells.
• Injured or intermediate subpopulation quantification.
• Viability percentage (survival rate) = active cells / total cells × 100%.
• Survival rate after stress exposure, including acid, bile salt, heat, osmotic, oxidative, or simulated gastrointestinal transit challenges.
• Viability retention over shelf life (storage-stability trend analysis).
• Correlation studies comparing AFU with colony-forming units (CFU) from culture-based enumeration.

Testing Methods

Sample Preparation

Samples are weighed, homogenized, and serially diluted in a suitable sterile buffer, typically phosphate-buffered saline or peptone saline supplemented with a dispersing agent when required by the matrix. Dairy and encapsulated products may require mild warming, agitation, or enzymatic and chemical treatment to fully disperse cells and break clumps. Suspensions are then gently filtered or settled to remove particulates that could clog the fluidic system, and the suspension is adjusted to fall within the optimal event-rate range of the instrument.

Fluorescent Staining

The working cell suspension is mixed with the fluorescent staining reagents, commonly CFDA or CFDA-AM for metabolic activity combined with PI for membrane integrity. Staining incubation is performed under controlled temperature and time conditions validated for the target strains. Dead-cell controls are prepared by heat treatment or alcohol exposure, and unstained controls are included to correct for autofluorescence. Stained suspensions are incubated in the dark and analyzed promptly to ensure signal stability.

Instrument Setup and Calibration

The flow cytometer is equipped with a 488 nm laser and fluorescence detection channels appropriate for green (e.g., 530/30 nm) and red (e.g., 610/20 nm or 670 nm) emission. Daily instrument qualification uses fluorescent calibration beads to verify fluidic stability, detector linearity, and PMT sensitivity. Counting beads of certified concentration may be spiked into samples to enable absolute concentration calculation, and event thresholds are set to exclude electronic noise and subcellular debris.

Data Acquisition and Gating Strategy

For each sample, typically 10,000 to 50,000 single-cell events are acquired. A gating hierarchy is applied: an FSC/SSC bacterial gate excludes debris, followed by a fluorescence gate or quadrant analysis on the green-versus-red fluorescence plot that separates active cells, dead cells, and intermediate populations. Concentrations are calculated from event counts, dilution factors, and either the known analyzed volume or the counting-bead ratio. Results are reported as total units, active units, and viability percentage, in accordance with ISO 19344 / IDF 232 calculation principles.

Quality Control and Validation

• Positive and negative staining controls run in each analytical batch.
• Replicate analysis with predefined precision acceptance criteria.
• Matrix-spiked recovery checks during method validation for new product formats.
• Periodic correlation verification between AFU values and reference plate-count methods (e.g., ISO 7889, ISO 20128, ISO 29981).
• Participation in interlaboratory comparisons and adherence to laboratory quality management systems consistent with ISO/IEC 17025 requirements.

Applications

Flow cytometric viability determination supports the entire life cycle of lactic acid bacteria products, from strain development to market surveillance:

• Quality control and batch release: rapid verification that probiotic finished products meet declared active cell counts before shipment.
• Shelf-life and stability studies: quantitative tracking of viability decay under real-time and accelerated storage conditions to support expiry-date substantiation.
• Process optimization: evaluation of fermentation endpoints, harvest timing, spray-drying and freeze-drying parameters, protectant formulations, and encapsulation technologies.
• Strain robustness screening: comparative survival testing of candidate strains under acid, bile, heat, and simulated gastrointestinal conditions.
• Research and development: mechanistic studies of stress responses, VBNC state characterization, and bacteriocin or postbiotic production monitoring.
• Regulatory and label compliance: generation of objective technical data for product documentation, health-claim dossiers, and dispute resolution.

FAQ

Q: How does flow cytometry differ from traditional plate counting for lactic acid bacteria?

A: Plate counting measures colony-forming units and requires 48–72 hours of incubation, counting only cells capable of reproduction under the chosen culture conditions. Flow cytometry analyzes individual cells within minutes based on physiological markers such as enzyme activity and membrane integrity, and it can enumerate stressed or dormant cells that fail to form colonies, providing a more complete picture of cell status.

Q: What are active fluorescent units (AFU)?

A: AFU is the unit defined in ISO 19344 / IDF 232 representing cells that exhibit measurable esterase activity and membrane retention of the fluorescent cleavage product. AFU quantifies metabolically active cells and is complementary, not strictly identical, to CFU.

Q: Can flow cytometry detect viable-but-non-culturable (VBNC) cells?

A: Yes. Cells that remain metabolically active but lose the ability to form colonies are still stained by activity probes and counted by flow cytometry, which explains why AFU values can exceed CFU values in stressed products.

Q: How much sample is required, and what is the turnaround time?

A: Typical submissions require 20–100 grams or a few units of finished product. Because staining and acquisition are completed within approximately one hour of preparation, testing reports are commonly available within three to five working days, depending on the scope of the test program.

Q: Is the method applicable to multi-strain products?

A: Yes. Generic viability staining works for mixed lactic acid bacteria formulations. However, when species- or strain-specific quantification is required, complementary culture-based methods (e.g., ISO 20128 for Lactobacillus acidophilus or ISO 29981 for bifidobacteria) or specific fluorescent markers validated for the target strains are recommended.

Q: How is result accuracy ensured?

A: Accuracy is ensured through validated staining protocols, calibrated instrumentation, appropriate controls in every batch, replicate precision checks, and correlation studies against reference culture methods, all performed under quality systems aligned with ISO/IEC 17025 in accredited third-party laboratories.